Search

Bo Peng

Examiner (ID: 16092)

Most Active Art Unit
1648
Art Unit(s)
4171, CQIC, 4111, 1648
Total Applications
343
Issued Applications
135
Pending Applications
38
Abandoned Applications
170

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5534062 [patent_doc_number] => 20090233850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'CVN-12p1: a recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions' [patent_app_type] => utility [patent_app_number] => 11/756567 [patent_app_country] => US [patent_app_date] => 2007-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14279 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20090233850.pdf [firstpage_image] =>[orig_patent_app_number] => 11756567 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/756567
CVN-12p1: a recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions May 30, 2007 Issued
Array ( [id] => 5091688 [patent_doc_number] => 20070231327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Anti-CCR5 antibodies' [patent_app_type] => utility [patent_app_number] => 11/805573 [patent_app_country] => US [patent_app_date] => 2007-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 14905 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0231/20070231327.pdf [firstpage_image] =>[orig_patent_app_number] => 11805573 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/805573
Anti-CCR5 antibodies May 22, 2007 Abandoned
Array ( [id] => 4681817 [patent_doc_number] => 20080248043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Antibodies to SARS coronavirus' [patent_app_type] => utility [patent_app_number] => 11/805129 [patent_app_country] => US [patent_app_date] => 2007-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 35332 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20080248043.pdf [firstpage_image] =>[orig_patent_app_number] => 11805129 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/805129
Antibodies to SARS coronavirus May 20, 2007 Issued
Array ( [id] => 5084935 [patent_doc_number] => 20070274986 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Compositions comprising anti-CCR5 antibody' [patent_app_type] => utility [patent_app_number] => 11/804746 [patent_app_country] => US [patent_app_date] => 2007-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14909 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20070274986.pdf [firstpage_image] =>[orig_patent_app_number] => 11804746 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/804746
Compositions comprising anti-CCR5 antibody May 16, 2007 Abandoned
Array ( [id] => 195517 [patent_doc_number] => 07635476 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-22 [patent_title] => 'Anti-hepatitis a virus antibodies' [patent_app_type] => utility [patent_app_number] => 11/789377 [patent_app_country] => US [patent_app_date] => 2007-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18288 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/635/07635476.pdf [firstpage_image] =>[orig_patent_app_number] => 11789377 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/789377
Anti-hepatitis a virus antibodies Apr 22, 2007 Issued
Array ( [id] => 6487684 [patent_doc_number] => 20100009341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'METHODS AND MEANS FOR ASSESSING HIV GAG/PROTEASE INHIBITOR THERAPY' [patent_app_type] => utility [patent_app_number] => 12/296987 [patent_app_country] => US [patent_app_date] => 2007-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9565 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20100009341.pdf [firstpage_image] =>[orig_patent_app_number] => 12296987 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/296987
METHODS AND MEANS FOR ASSESSING HIV GAG/PROTEASE INHIBITOR THERAPY Apr 12, 2007 Abandoned
Array ( [id] => 7555111 [patent_doc_number] => 08067011 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-29 [patent_title] => 'Compositions and methods for treating B-cell malignancies' [patent_app_type] => utility [patent_app_number] => 11/697945 [patent_app_country] => US [patent_app_date] => 2007-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11191 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/067/08067011.pdf [firstpage_image] =>[orig_patent_app_number] => 11697945 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/697945
Compositions and methods for treating B-cell malignancies Apr 8, 2007 Issued
Array ( [id] => 5247353 [patent_doc_number] => 20070243587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-18 [patent_title] => 'Using a reverse genetic engineering platform to produce protein vaccines and protein vaccine of avian influenza virus' [patent_app_type] => utility [patent_app_number] => 11/783300 [patent_app_country] => US [patent_app_date] => 2007-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 7992 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20070243587.pdf [firstpage_image] =>[orig_patent_app_number] => 11783300 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/783300
Using a reverse genetic engineering platform to produce protein vaccines and protein vaccine of avian influenza virus Apr 8, 2007 Abandoned
Array ( [id] => 5354681 [patent_doc_number] => 20090186025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'Fusion Protein Comprising an Fc Receptor Binding Polypeptide and an Antigenic Polypeptide for Mediating an Immune Response' [patent_app_type] => utility [patent_app_number] => 12/225454 [patent_app_country] => US [patent_app_date] => 2007-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15856 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186025.pdf [firstpage_image] =>[orig_patent_app_number] => 12225454 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/225454
Fusion Protein Comprising an Fc Receptor Binding Polypeptide and an Antigenic Polypeptide for Mediating an Immune Response Mar 21, 2007 Abandoned
Array ( [id] => 5177503 [patent_doc_number] => 20070178563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-02 [patent_title] => 'Mosaic infectious bursal disease virus vaccines' [patent_app_type] => utility [patent_app_number] => 11/717293 [patent_app_country] => US [patent_app_date] => 2007-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 42960 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0178/20070178563.pdf [firstpage_image] =>[orig_patent_app_number] => 11717293 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/717293
Mosaic infectious bursal disease virus vaccines Mar 11, 2007 Abandoned
Array ( [id] => 6302366 [patent_doc_number] => 20100068213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-18 [patent_title] => 'SELECTED COLOSTRUM FOR TREATMENT OF INTESTINAL BARRIER FUNCTION DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/527772 [patent_app_country] => US [patent_app_date] => 2007-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 3783 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20100068213.pdf [firstpage_image] =>[orig_patent_app_number] => 12527772 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/527772
SELECTED COLOSTRUM FOR TREATMENT OF INTESTINAL BARRIER FUNCTION DISORDERS Feb 19, 2007 Abandoned
Array ( [id] => 4824775 [patent_doc_number] => 20080124272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'Influenza antibodies, compositions, and related methods' [patent_app_type] => utility [patent_app_number] => 11/707257 [patent_app_country] => US [patent_app_date] => 2007-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 28454 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20080124272.pdf [firstpage_image] =>[orig_patent_app_number] => 11707257 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/707257
Influenza antibodies, compositions, and related methods Feb 12, 2007 Abandoned
Array ( [id] => 6603015 [patent_doc_number] => 20100292445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'Method for Efficient Purification of Bionanocapsule' [patent_app_type] => utility [patent_app_number] => 12/223864 [patent_app_country] => US [patent_app_date] => 2007-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5649 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292445.pdf [firstpage_image] =>[orig_patent_app_number] => 12223864 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/223864
Method for Efficient Purification of Bionanocapsule Feb 8, 2007 Abandoned
Array ( [id] => 5100803 [patent_doc_number] => 20070184065 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-09 [patent_title] => 'Compositions and Methods for Inhibiting Viral Adhesion' [patent_app_type] => utility [patent_app_number] => 11/627548 [patent_app_country] => US [patent_app_date] => 2007-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9012 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20070184065.pdf [firstpage_image] =>[orig_patent_app_number] => 11627548 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/627548
Compositions and Methods for Inhibiting Viral Adhesion Jan 25, 2007 Abandoned
Array ( [id] => 5452600 [patent_doc_number] => 20090068637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'MONOCLONAL ANTIBODIES BINDING TO AVIAN INFLUENZA VIRUS SUBTYPE H5 HAEMAGGLUTININ AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/162343 [patent_app_country] => US [patent_app_date] => 2007-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 38530 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068637.pdf [firstpage_image] =>[orig_patent_app_number] => 12162343 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/162343
MONOCLONAL ANTIBODIES BINDING TO AVIAN INFLUENZA VIRUS SUBTYPE H5 HAEMAGGLUTININ AND USE THEREOF Jan 25, 2007 Abandoned
Array ( [id] => 5253335 [patent_doc_number] => 20070134791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Cells for detection of enteroviruses' [patent_app_type] => utility [patent_app_number] => 11/657822 [patent_app_country] => US [patent_app_date] => 2007-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17974 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20070134791.pdf [firstpage_image] =>[orig_patent_app_number] => 11657822 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/657822
Cells for detection of enteroviruses Jan 22, 2007 Issued
Array ( [id] => 5367124 [patent_doc_number] => 20090304683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'Soluble Fragments of The Sars-Cov Spike Glycoprotein' [patent_app_type] => utility [patent_app_number] => 12/087306 [patent_app_country] => US [patent_app_date] => 2007-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 32413 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0304/20090304683.pdf [firstpage_image] =>[orig_patent_app_number] => 12087306 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/087306
Soluble Fragments of The Sars-Cov Spike Glycoprotein Jan 18, 2007 Abandoned
Array ( [id] => 4670394 [patent_doc_number] => 20080045454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Polynucleotide encoding a TRIM-cyp polypeptide, compositions thereof, and methods of using same' [patent_app_type] => utility [patent_app_number] => 11/650384 [patent_app_country] => US [patent_app_date] => 2007-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 14791 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045454.pdf [firstpage_image] =>[orig_patent_app_number] => 11650384 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/650384
Polynucleotide encoding a TRIM-Cyp polypeptide, compositions thereof, and methods of using same Jan 4, 2007 Issued
Array ( [id] => 4455510 [patent_doc_number] => 07892754 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-22 [patent_title] => 'Hepatitis B virus pre-S1 derived synthetic polypeptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/641066 [patent_app_country] => US [patent_app_date] => 2006-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 5556 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/892/07892754.pdf [firstpage_image] =>[orig_patent_app_number] => 11641066 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/641066
Hepatitis B virus pre-S1 derived synthetic polypeptides and uses thereof Dec 18, 2006 Issued
Array ( [id] => 8189596 [patent_doc_number] => 08183352 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-22 [patent_title] => 'Attenuated vif DNA immunization cassettes for genetic vaccines' [patent_app_type] => utility [patent_app_number] => 11/639542 [patent_app_country] => US [patent_app_date] => 2006-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 21 [patent_no_of_words] => 13410 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/183/08183352.pdf [firstpage_image] =>[orig_patent_app_number] => 11639542 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/639542
Attenuated vif DNA immunization cassettes for genetic vaccines Dec 14, 2006 Issued
Menu